v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2021   223,724        
Beginning balance at Jan. 31, 2021 $ 871,874 $ 112 $ 1,598,259 $ (730,116) $ 2,319 $ 1,300
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   2,136        
Issuance of common stock upon exercise of options 12,796 $ 2 12,794      
Issuance of common stock under RSU and PSU release (in shares)   2,680        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   689        
Issuance of common stock under employee stock purchase plan 27,452   27,452      
Issuance of common stock for restricted stock awards (in shares)   57        
Vesting of early exercised stock options 2,389   2,389      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   11        
Issuance of common stock for founders holdbacks related to acquisitions 2,867   2,867      
Stock-based compensation expense 214,716   214,716      
Capitalized stock-based compensation 7,633   7,633      
Fair value of replacement equity awards attributable to pre-acquisition service 4,011   4,011      
Net income (loss) (190,639)     (192,822)   2,183
Non-controlling interest 7,905         7,905
Other comprehensive loss (1,434)       (1,434)  
Ending balance (in shares) at Oct. 31, 2021   229,297        
Ending balance at Oct. 31, 2021 959,570 $ 115 1,870,120 (922,938) 885 11,388
Beginning balance (in shares) at Jul. 31, 2021   228,152        
Beginning balance at Jul. 31, 2021 911,401 $ 114 1,775,087 (872,483) 1,550 7,133
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   375        
Issuance of common stock upon exercise of options 2,580 $ 0 2,580      
Issuance of common stock under RSU and PSU release (in shares)   759        
Issuance of common stock under RSU and PSU release 0 $ 1 (1)      
Vesting of early exercised stock options 795   795      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   11        
Issuance of common stock for founders holdbacks related to acquisitions 2,867   2,867      
Stock-based compensation expense 85,706   85,706      
Capitalized stock-based compensation 3,086   3,086      
Net income (loss) (50,450)     (50,455)   5
Non-controlling interest 4,250         4,250
Other comprehensive loss (665)       (665)  
Ending balance (in shares) at Oct. 31, 2021   229,297        
Ending balance at Oct. 31, 2021 959,570 $ 115 1,870,120 (922,938) 885 11,388
Beginning balance (in shares) at Jan. 31, 2022   230,706        
Beginning balance at Jan. 31, 2022 $ 1,037,643 $ 115 1,991,807 (964,918) (1,240) 11,879
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares) 778 779        
Issuance of common stock upon exercise of options $ 6,396 $ 2 6,394      
Issuance of common stock under RSU and PSU release (in shares)   2,572        
Issuance of common stock under employee stock purchase plan (in shares)   263        
Issuance of common stock under employee stock purchase plan 34,445   34,445      
Issuance of common stock for restricted stock awards (in shares)   6        
Vesting of early exercised stock options 2,204   2,204      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   35        
Issuance of common stock for founders holdbacks related to acquisitions 6,328   6,328      
Stock-based compensation expense 369,012   369,012      
Capitalized stock-based compensation 13,798   13,798      
Fair value of replacement equity awards attributable to pre-acquisition service 50   50      
Net income (loss) (133,353)     (135,764)   2,411
Non-controlling interest 9,053         9,053
Other comprehensive loss (7,944)       (7,944)  
Ending balance (in shares) at Oct. 31, 2022   234,361        
Ending balance at Oct. 31, 2022 1,337,632 $ 117 2,424,038 (1,100,682) (9,184) 23,343
Beginning balance (in shares) at Jul. 31, 2022   233,368        
Beginning balance at Jul. 31, 2022 1,243,347 $ 116 2,276,704 (1,045,726) (5,675) 17,928
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   146        
Issuance of common stock upon exercise of options 1,478 $ 1 1,477      
Issuance of common stock under RSU and PSU release (in shares)   834        
Issuance of common stock for restricted stock awards (in shares)   6        
Vesting of early exercised stock options 734   734      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   7        
Issuance of common stock for founders holdbacks related to acquisitions 1,201   1,201      
Stock-based compensation expense 138,453   138,453      
Capitalized stock-based compensation 5,419   5,419      
Fair value of replacement equity awards attributable to pre-acquisition service 50   50      
Net income (loss) (54,631)     (54,956)   325
Non-controlling interest 5,090         5,090
Other comprehensive loss (3,509)       (3,509)  
Ending balance (in shares) at Oct. 31, 2022   234,361        
Ending balance at Oct. 31, 2022 $ 1,337,632 $ 117 $ 2,424,038 $ (1,100,682) $ (9,184) $ 23,343